Smoking cessation drug ‘does not increase self-harm or depression risk’
October 2nd, 2009 - 1:28 pm ICT by ANILondon, Oct 2 (ANI): Popular smoking cessation drug varenicline doesn’t increase the risk of self-harm or depression, according to a new study.
Researchers from the University of Bristol and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) compared the risk of self harm among people taking varenicline with the risk of self harm associated with other smoking cessation products bupropion and nicotine replacement therapy (patch, inhaler, gum, tablet or lozenge).
The participants were prescribed nicotine replacement products varenicline, or bupropion, reports British Medical Journal.
After controlling for confounding factors, the researchers found no clear evidence of an increased risk of self-harm, suicidal thoughts or depression associated with either varenicline or bupropion.
Although the researchers found no strong evidence of an increased risk of self harm linked to varenicline, “the limited power of the study means we cannot rule out either a halving or a twofold increased risk.”
They call for more investigation of varenicline’s effect on suicide risk in other databases and secondary analysis of all adverse event reporting in clinical trials. (ANI)
- Nicotine patch and lozenge can help smokers quit - Nov 06, 2009
- Want to quit smoking? Get professional help - Jan 04, 2011
- How anti-smoking drugs may curb cravings - Jan 04, 2011
- Web, phone counseling may help smokers kick the butt - May 19, 2010
- Problem-solving therapy may prevent suicides - Sep 30, 2011
- Nicotine chewing gums 'raise cancer risk' - Apr 22, 2009
- E-ciggies 'are a promising tool to help smokers quit' - Feb 09, 2011
- Personalized approach to smoking cessation may soon be a reality - Jul 03, 2010
- Common anxiety disorders make it tougher to kick the butt - Oct 26, 2010
- Nicotine patch, lozenge combo 'helps kick the butt' - Nov 03, 2009
- New 'dissolvable tobacco' products up mouth disease risk - Mar 17, 2011
- Quit-smoking drug 'instigates suicidal tendencies' - Aug 04, 2010
- Toenails may hold clue to lung cancer risk - Mar 05, 2011
- Ceasing smoking therapy sooner could cut odds of success by 45 pct - Sep 02, 2010
- Certain epilepsy drugs may increase suicide risk - Jul 27, 2010
Tags: british medical journal, bupropion, clear evidence, clinical trials, gum, healthcare products regulatory agency, limited power, medicines and healthcare products regulatory agency, nicotine, nicotine replacement products, nicotine replacement therapy, self harm, smoking cessation, smoking cessation drug, smoking cessation products, study researchers, suicidal thoughts, suicide risk, university of bristol, varenicline
